title: Gemcitabine induced cardiomyopathy: a case of multiple hit cardiotoxicity.
abstract: Gemcitabine is a commonly used antineoplastic agent used to treat a variety of cancers with rarely reported cardiac side effects. We describe a case of a 67-year-old woman with follicular lymphoma who experienced a rarely reported side effect of gemcitabine: cardiomyopathy. This case highlights a multiple hit mechanism of myocyte damage that may occur following the use of multiple cardio-toxic agents despite their administration in doses not associated with cardiotoxicity.
authors.affiliation: Department of Internal Medicine Beth Israel Deaconess Medical Center Boston MA USA.
authors.forename: Donya
authors.initials: D
authors.lastname: Mohebali
authors.affiliation: Department of Internal Medicine, Division of Cardiology Beth Israel Deaconess Medical Center Boston MA USA.
authors.forename: Jason
authors.initials: J
authors.lastname: Matos
authors.affiliation: Program in Cardio-oncology, Department of Internal Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA.
authors.forename: James Ducksoon
authors.initials: JD
authors.lastname: Chang
keywords: Cardiomyopathy; Cardio‐oncology; Chemotherapy